Literature DB >> 21983082

Reduced expression of UGT1A1 in intestines of humanized UGT1 mice via inactivation of NF-κB leads to hyperbilirubinemia.

Ryoichi Fujiwara1, Shujuan Chen, Michael Karin, Robert H Tukey.   

Abstract

BACKGROUND & AIMS: Bilirubin is a natural and potent antioxidant that accumulates in the blood of newborn children and leads to physiological jaundice. Breastfed infants have higher serum levels of bilirubin than formula-fed infants and are at risk for bilirubin-induced neurological dysfunction (BIND). Clearance of bilirubin requires the expression of uridine diphosphate glucuronosyltransferase (UGT) 1A1; we investigated its role in the association between breast feeding with jaundice in mice.
METHODS: We studied mice in which the original Ugt1 locus was disrupted and replaced with the human UGT1 locus (hUGT1 mice); these mice spontaneously develop neonatal hyperbilirubinemia and BIND. We fed human breast milk or formula to neonatal hUGT1 mice and examined activation of the intestinal xenobiotic receptors pregnane X receptor and constitutive androstane receptor. We also examined inflammatory signaling pathways in mice with disruptions in IκB-kinase-α and IκB kinase-β in the intestinal epithelium.
RESULTS: hUGT1 mice that were fed breast milk developed severe hyperbilirubinemia because of suppression of UGT1A1 in the gastrointestinal tract. Formula-fed hUGT1 mice had lower serum levels of bilirubin, which resulted from induction of UGT1A1 in the gastrointestinal tract. hUGT1/Pxr-null mice did not develop severe hyperbilirubinemia, whereas hUGT1/Car-null mice were susceptible to BIND when they were fed breast milk. Breast milk appeared to suppress intestinal IκB kinase α and β, resulting in inactivation of nuclear factor-κB and loss of expression of UGT1A1, leading to hyperbilirubinemia.
CONCLUSIONS: Breast milk reduces expression of intestinal UGT1A1, which leads to hyperbilirubinemia and BIND; suppression of this gene appears to involve inactivation of nuclear factor-κB. Hyperbilirubinemia can be reduced by activation of pregnane X receptor, constitutive androstane receptor, or nuclear factor-κB.
Copyright © 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21983082      PMCID: PMC3428231          DOI: 10.1053/j.gastro.2011.09.045

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  50 in total

1.  Humanized xenobiotic response in mice expressing nuclear receptor SXR.

Authors:  W Xie; J L Barwick; M Downes; B Blumberg; C M Simon; M C Nelson; B A Neuschwander-Tetri; E M Brunt; P S Guzelian; R M Evans
Journal:  Nature       Date:  2000-07-27       Impact factor: 49.962

2.  Tissue-specific, inducible, and hormonal control of the human UDP-glucuronosyltransferase-1 (UGT1) locus.

Authors:  Shujuan Chen; Deirdre Beaton; Nghia Nguyen; Kathy Senekeo-Effenberger; Erin Brace-Sinnokrak; Upendra Argikar; Rory P Remmel; Jocelyn Trottier; Olivier Barbier; Joseph K Ritter; Robert H Tukey
Journal:  J Biol Chem       Date:  2005-09-09       Impact factor: 5.157

3.  Serum bilirubin and 10-year mortality risk in a Belgian population.

Authors:  E H Temme; J Zhang; E G Schouten; H Kesteloot
Journal:  Cancer Causes Control       Date:  2001-12       Impact factor: 2.506

4.  Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels.

Authors:  Libor Vítek; Milan Jirsa; Marie Brodanová; Milan Kalab; Zdenek Marecek; Vilém Danzig; Ladislav Novotný; Petr Kotal
Journal:  Atherosclerosis       Date:  2002-02       Impact factor: 5.162

5.  The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity.

Authors:  J L Staudinger; B Goodwin; S A Jones; D Hawkins-Brown; K I MacKenzie; A LaTour; Y Liu; C D Klaassen; K K Brown; J Reinhard; T M Willson; B H Koller; S A Kliewer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

Review 6.  Hyperbilirubinemia and bilirubin toxicity in the late preterm infant.

Authors:  Jon F Watchko
Journal:  Clin Perinatol       Date:  2006-12       Impact factor: 3.430

7.  Expression of the human UGT1 locus in transgenic mice by 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic acid (WY-14643) and implications on drug metabolism through peroxisome proliferator-activated receptor alpha activation.

Authors:  Kathy Senekeo-Effenberger; Shujuan Chen; Erin Brace-Sinnokrak; Jessica A Bonzo; Mei-Fei Yueh; Upendra Argikar; Jenny Kaeding; Jocelyn Trottier; Rory P Remmel; Joseph K Ritter; Olivier Barbier; Robert H Tukey
Journal:  Drug Metab Dispos       Date:  2006-12-06       Impact factor: 3.922

8.  Residue threonine 350 confers steroid hormone responsiveness to the mouse nuclear orphan receptor CAR.

Authors:  Akiko Ueda; Satoru Kakizaki; Masahiko Negishi; Tatsuya Sueyoshi
Journal:  Mol Pharmacol       Date:  2002-06       Impact factor: 4.436

9.  Transcriptional regulation of human UGT1A1 gene expression: activated glucocorticoid receptor enhances constitutive androstane receptor/pregnane X receptor-mediated UDP-glucuronosyltransferase 1A1 regulation with glucocorticoid receptor-interacting protein 1.

Authors:  Junko Sugatani; Shinichi Nishitani; Kasumi Yamakawa; Kouichi Yoshinari; Tatsuya Sueyoshi; Masahiko Negishi; Masao Miwa
Journal:  Mol Pharmacol       Date:  2004-11-22       Impact factor: 4.436

10.  Imbalance between production and conjugation of bilirubin: a fundamental concept in the mechanism of neonatal jaundice.

Authors:  Michael Kaplan; Maurizio Muraca; Cathy Hammerman; Firmino F Rubaltelli; Maria T Vilei; Hendrik J Vreman; David K Stevenson
Journal:  Pediatrics       Date:  2002-10       Impact factor: 7.124

View more
  29 in total

1.  Bilirubin uridine diphosphate-glucuronosyltransferase variation is a genetic basis of breast milk jaundice.

Authors:  Yoshihiro Maruo; Yoriko Morioka; Hiroshi Fujito; Sayuri Nakahara; Takahide Yanagi; Katsuyuki Matsui; Asami Mori; Hiroshi Sato; Robert H Tukey; Yoshihiro Takeuchi
Journal:  J Pediatr       Date:  2014-03-17       Impact factor: 4.406

2.  Glucuronidation of drugs and drug-induced toxicity in humanized UDP-glucuronosyltransferase 1 mice.

Authors:  Yuki Kutsuno; Tomoo Itoh; Robert H Tukey; Ryoichi Fujiwara
Journal:  Drug Metab Dispos       Date:  2014-04-24       Impact factor: 3.922

3.  Hepatic expression of transcription factors affecting developmental regulation of UGT1A1 in the Han Chinese population.

Authors:  Ya-Li Nie; Hang He; Jiang-Feng Li; Xiang-Guang Meng; Liang Yan; Pei Wang; Shu-Jie Wang; Hong-Zheng Bi; Li-Rong Zhang; Quan-Cheng Kan
Journal:  Eur J Clin Pharmacol       Date:  2016-10-05       Impact factor: 2.953

4.  Molecular modeling to provide insight into the substrate binding and catalytic mechanism of human biliverdin-IXα reductase.

Authors:  Gang Fu; Haining Liu; Robert J Doerksen
Journal:  J Phys Chem B       Date:  2012-08-07       Impact factor: 2.991

5.  Humanized UGT1 Mice, Regulation of UGT1A1, and the Role of the Intestinal Tract in Neonatal Hyperbilirubinemia and Breast Milk-Induced Jaundice.

Authors:  Shujuan Chen; Robert H Tukey
Journal:  Drug Metab Dispos       Date:  2018-08-09       Impact factor: 3.922

6.  Gene Mutation in Neonatal Jaundice - Mutations in UGT1A1 and OATP2 Genes.

Authors:  Jiang Min; Luo Jie; Yang Caiyun; Lin Ying; Yang Xuefang
Journal:  Indian J Pediatr       Date:  2016-03-10       Impact factor: 1.967

Review 7.  Developmental, Genetic, Dietary, and Xenobiotic Influences on Neonatal Hyperbilirubinemia.

Authors:  Mei-Fei Yueh; Shujuan Chen; Nghia Nguyen; Robert H Tukey
Journal:  Mol Pharmacol       Date:  2017-03-10       Impact factor: 4.436

8.  Prediction of drug-induced liver injury using keratinocytes.

Authors:  Rika Hirashima; Tomoo Itoh; Robert H Tukey; Ryoichi Fujiwara
Journal:  J Appl Toxicol       Date:  2017-01-31       Impact factor: 3.446

9.  Nicotine regulates the expression of UDP-glucuronosyltransferase (UGT) in humanized UGT1 mouse brain.

Authors:  Masaya Sakamoto; Tomoo Itoh; Robert H Tukey; Ryoichi Fujiwara
Journal:  Drug Metab Pharmacokinet       Date:  2015-05-07       Impact factor: 3.614

10.  Cadmium and arsenic override NF-κB developmental regulation of the intestinal UGT1A1 gene and control of hyperbilirubinemia.

Authors:  Miao Liu; Shujuan Chen; Mei-Fei Yueh; Ryoichi Fujiwara; Camille Konopnicki; Haiping Hao; Robert H Tukey
Journal:  Biochem Pharmacol       Date:  2016-04-06       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.